TPC
AKLI

Takeda Pharmaceutical Company’s Akili Inc AKLI Stock Holding History

Takeda Pharmaceutical Company’s Portfolio AKLI Stock Details AKLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-738,819
Closed -$321K – 13
2024
Q2 		$321K Hold
738,819
– – 0.14% 12
2024
Q1 		$214K Hold
738,819
– – 0.07% 14
2023
Q4 		$360K Buy
+738,819
New +$341K 0.11% 12

Takeda Pharmaceutical Company's AKLI Position: Q3 2024 in Review

Takeda Pharmaceutical Company sold out of Akili Inc (AKLI) in Q3 2024, closing a stake of 738,819 shares — an estimated $321K sold.

Takeda Pharmaceutical Company first reported a position in AKLI in Q4 2023 and held it in 3 quarters. The position peaked at $360K in Q4 2023. 0 funds tracked by Wall St. Rank hold AKLI as of Q3 2024.

  • Takeda Pharmaceutical Company reported no remaining Akili Inc position as of Q3 2024 after selling out during the quarter.
  • Takeda Pharmaceutical Company sold 738,819 Akili Inc shares in Q3 2024, an estimated $321K.
  • Takeda Pharmaceutical Company first reported a position in Akili Inc in Q4 2023 and held it in 3 quarters.
  • Takeda Pharmaceutical Company's Akili Inc position peaked at $360K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Akili Inc as of Q3 2024.

Based on Takeda Pharmaceutical Company's 13F filing for Q3 2024, filed 13 Feb 2025.